Platform
Company
Coagulation
Review status
Currently under review
Pending specialist review and validation.
Fibrinogen is a protein made by your liver that is essential for blood clotting. It is also known as coagulation factor I. When you are injured, an enzyme called thrombin converts fibrinogen into fibrin, forming a mesh that helps stop bleeding. The test typically measures the functional activity of fibrinogen in your plasma using a clot-based method, and in some settings the amount of fibrinogen protein may also be assessed.
This test is part of evaluating bleeding and clotting problems, liver function, and inflammatory states. Your blood is collected into a citrate tube, then processed to measure how well fibrinogen supports clot formation in a controlled assay.
Fibrinogen levels help your care team understand why bleeding is occurring or whether you are at risk of bleeding with procedures. Low levels can be seen in inherited fibrinogen disorders, in severe liver disease, or when the body is rapidly using up clotting factors. The test is also used to monitor critical illnesses where clotting and bleeding can occur together.
Higher fibrinogen levels often reflect inflammation or physiologic stress and have been associated with cardiovascular risk in population studies. Clinicians may order this test before surgery, during major bleeding, or to guide therapy such as cryoprecipitate or fibrinogen concentrate. It is commonly interpreted alongside other coagulation tests like PT, aPTT, thrombin time, platelet count, and D-dimer to give a complete picture.
If your fibrinogen is lower than expected, your clinician will consider inherited conditions that affect fibrinogen, liver dysfunction, or illnesses that consume clotting factors. They will also review medications, recent bleeding, transfusions, and sample handling. Follow-up may include repeating the test when you are stable, performing specialized assays, or occasionally genetic testing. Treatment focuses on the underlying cause and, during active bleeding, may include targeted replacement under specialist guidance.
If your fibrinogen is higher than expected, this usually reflects an acute-phase response from infection, inflammation, pregnancy, or lifestyle factors such as smoking. Your care team may address contributing conditions and recheck levels after recovery. Interpreting this result in context with other tests and your medical history helps decide whether any action is needed.
Reference intervals vary by laboratory, analyzer, methodology, population, and units. The ranges shown here are for education only. Always interpret your results against the reference interval printed on your own lab report.
Improper fill volume or poor mixing in the blue-top citrate tube can falsely alter clot-based fibrinogen results. Ensure the tube is filled to the mark and gently inverted as instructed.
Heparin, direct thrombin inhibitors, and direct factor Xa inhibitors can affect functional assays and make fibrinogen appear lower. Labs may use neutralizers or alternative methods when interference is suspected.
Fibrinogen rises as part of the acute-phase response during infection, injury, surgery, or chronic inflammatory disease. Levels often normalize once the triggering condition improves.
Because fibrinogen is produced in the liver, impaired liver function can lower levels. Conditions like disseminated intravascular coagulation can also consume fibrinogen faster than it is made.
Estrogen-containing therapies and pregnancy can increase fibrinogen, while fibrates, androgens, and thrombolytic drugs can lower it. Always share your medication list with the lab and clinician.
Large-volume fluid resuscitation or transfusion without adequate plasma replacement can dilute fibrinogen, especially during major bleeding or surgery.
Clotted samples, significant hemolysis, or delays in processing can produce misleading results. Proper collection, prompt centrifugation, and timely testing reduce these errors.
References